Post-earnings recap
Reported
Thu, Aug 7, 2025
EPS actual
$0.70
EPS est.
$1.04
EPS surprise
-32.69%
1-day move
-26.58%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Haemonetics Corp struggled to meet expectations, particularly with its EPS, resulting in a significant stock drop of 26.58%. The lack of guidance and management's defensive tone suggest uncertainty about the company's near-term performance. Investors may be cautious as the company works to address its operational challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.70 | N/A | -32.69% |
Management expressed concern over recent performance but highlighted plans for operational enhancements. They did not provide specific guidance for future quarters.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on operational improvements moving forward.